Pneumonia in US hospitalized patients with influenza-like illness: BioSense, 2007-2010

Epidemiology and Infection

Volumn 141, Issue 4, 2013, Pages 805-815

  Benoit, S R ^a   Burkom, H ^b   Mcintyre, A F ^c   Kniss, K ^c   Brammer, L ^c   Finelli, L ^c   Jain, S ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b JOHNS HOPKINS UNIVERSITY APPLIED PHYSICS LABORATORY   (United States)

^c NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

Epidemiology; influenza; pneumonia; public health; surveillance system

Indexed keywords

OSELTAMIVIR; ZANAMIVIR;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIVIRAL THERAPY; ARTICLE; BLOODSTREAM INFECTION; CHILD; CONTROLLED STUDY; DISEASE SURVEILLANCE; ELECTRONIC MEDICAL RECORD; FLU LIKE SYNDROME; HOSPITAL PATIENT; HUMAN; ICD-9-CM; INFANT; MAJOR CLINICAL STUDY; PANDEMIC; PNEUMONIA; PRESCHOOL CHILD; PRESCRIPTION; SCHOOL CHILD; SEASONAL VARIATION; TREND STUDY; UNITED STATES;

ADOLESCENT; ADULT; AGE FACTORS; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; ELECTRONIC HEALTH RECORDS; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INFLUENZA, HUMAN; INPATIENTS; LOGISTIC MODELS; MALE; MIDDLE AGED; PNEUMONIA; POPULATION SURVEILLANCE; UNITED STATES;

EID: 84874484479     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268812001549     Document Type: Article

References (32)

1. Thompson WW, et al. Influenza-Associated hospitalizations in the United States. Journal of the American Medical Association 2004; 292: 1333-1340
2. Thompson MG, et al. Estimates of deaths associated with seasonal influenza - United States, 1976-2007. Morbidity and Mortality Weekly Report 2010; 59: 1057-1062
3. Centers for Disease Control and Prevention. Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. Morbidity and Mortality Weekly Report 2010; 59: 1-62
4. Dao CN, et al. Adult hospitalizations for laboratorypositive influenza during the 2005-2006 through 2007-2008 seasons in the United States. Journal of Infectious Diseases 2010; 202: 881-888
5. Dawood FS, et al. Influenza-Associated pneumonia in children hospitalized with laboratory-confirmed influenza, 2003-2008. Pediatric Infectious Disease Journal 2010; 29: 585-590
6. Jain S, et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. New England Journal of Medicine 2009; 361: 1935-1944
7. Skarbinski J, et al. Hospitalized patients with 2009 pandemic influenza A (H1N1) virus infection in the United States - September-October 2009. Clinical Infectious Diseases 2011; 52: S50-S59
8. Belongia EA, et al. Clinical characteristics and 30-day outcomes for influenza A 2009 (H1N1), 2008-2009 (H1N1), and 2007-2008 (H3N2) infections. Journal of the American Medical Association 2010; 304: 1091-1098
9. Louie JK, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. Journal of the American Medical Association 2009; 302: 1896-1902
10. Loonsk JW. BioSense - A national initiative for early detection and quantification of public health emergencies. Morbidity and Mortality Weekly Report 2004; 53: 53-55
11. Bradley CA, et al. BioSense: Implementation of a National Early Event Detection and Situational Awareness System. Morbidity and Mortality Weekly Report 2005; 54: 11-19
12. Tokars JI, et al. Summary of data reported to CDC's national automated biosurveillance system, 2008. BioMed Central Medical Informatics and Decision Making 2010; 10: 30
13. The BioSense Influenza Module (http://www.syndromic. org/conference/2008/ presentations/powerpoints.htm). Accessed 16 June 2011
14. Centers for Disease Control and Prevention (http:// www.cdc.gov/flu/ weekly/overview.htm). Accessed 20 March 2011
15. Brammer L, et al. Surveillance for influenza during the 2009 influenza A (H1N1) pandemic-United States, April 2009-March 2010. Clinical Infectious Diseases 2011; 52: S27-S35
16. Monto AS, et al. Clinical signs and symptoms predicting influenza infection. Archives of Internal Medicine 2000; 160: 3243-3247
17. Boivin G, et al. Predicting influenza infections during epidemics with use of a clinical case definition. Clinical Infectious Diseases 2000; 31: 1166-1169
18. Elixhauser A, McCarthy EM. Clinical classifications for health policy research, version 2: Hospital inpatient statistics. Healthcare Cost and Utilization Project (HCUP 3) Research Note 1. Rockville, MD: Agency for Health Care Policy and Research, 1996; AHCPR Pub. No. 96 0017 (http://www.hcup-us.ahrq. gov/toolssoftware/ ccs/ccs.jsp). Accessed 10 March 2011
19. Mullooly JP, et al. Influenza- And RSV-Associated hospitalizations among adults. Vaccine 2007; 25: 846-855
20. Benoit SR, et al. Automated surveillance of Clostridium difficile infections using BioSense. Infection Control and Hospital Epidemiology 2011; 32: 26-33
21. Pien BC, et al. The clinical and prognostic importance of positive blood cultures in adults. American Journal of Medicine 2010; 123: 819-828
22. Kallen AJ, et al. Health care-Associated invasive MRSA infections, 2005-2008. Journal of the American Medical Association 2010; 304: 641-648
23. Hall MJ, et al. National Hospital Discharge Survey: 2007 Summary. National health statistics reports; no. 29. Hyattsville, MD: National Center for Health Statistics, 2010
24. Brundage JF. Interactions between influenza and bacterial respiratory pathogens: Implications for pandemic preparedness. Lancet Infectious Diseases 2006; 6: 303-312
25. Hers JF, Masurel N, Mulder J. Bacteriology and histopathology of the respiratory tract and lungs in fatal Asian influenza. Lancet 1958; 2: 1141-1143
26. Peltola VT, McCullers JA. Respiratory viruses predisposing to bacterial infections: Role of neuraminidase. Pediatric Infectious Disease Journal 2004; 23: S87-S97
27. Nickerson CL, Jakab GJ. Pulmonary antibacterial defenses during mild and severe influenza virus infection. Infection and Immunity 1990; 58: 2809-2814
28. Jakab GJ. Immune impairment of alveolar macrophage phagocytosis during influenza virus pneumonia. American Review of Respiratory Disease 1982; 126: 778-782
29. Centers for Disease Control and Prevention (http:// www.cdc.gov/H1N1flu/ recommendations.htm#c). Accessed 2 May 2011
30. Doshi S, et al. Comparison of antiviral treatment among hospitalized adults before and during the 2009 influenza pandemic - United States, 2005-09. Proceedings of the 48th Annual Meeting of the IDSA. 21-24 October, 2010. Vancouver, Canada: Infectious Diseases Society of America, 2010
31. Fiore AE, et al. Antiviral agents for the treatment and chemoprophylaxis of influenza - recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report 2011; 60: 1-24
32. Marsden-Haug N, et al. Code-based syndromic surveillance for influenza-like illness by International Classification of Diseases, Ninth Revision. Emerging Infectious Diseases 2007; 13: 207-216. Pneumonia in patients with ILI 815